RNA-seq analysis of plasma extracellular vesicles from Lung Squamous Cell Carcinoma (LUSC) patients
We enrolled advanced LUSC patients undergoing first-line immunochemotherapy and conducted plasma extracellular vesicle (EV)-derived long RNAs (exLRs) sequencing to identify potential biomarkers for immunochemotherapy efficacy.